Top compounds associated with response to NMS


Feature Type Standardized
Nominal ANOVA
mRNA ML239 CTRPv2 pan-cancer AAC 0.065 0.06
mRNA Topotecan CTRPv2 pan-cancer AAC -0.058 0.06
mRNA VX-680 GDSC1000 pan-cancer AAC -0.096 0.06
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.062 0.06
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.057 0.06
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.06
mRNA salermide CTRPv2 pan-cancer AAC -0.082 0.07
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.056 0.07
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.059 0.07
Download CSV